RUBINO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 11.875
EU - Europa 6.520
AS - Asia 3.795
SA - Sud America 488
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 6
Totale 22.763
Nazione #
US - Stati Uniti d'America 11.713
IT - Italia 3.423
SG - Singapore 1.325
UA - Ucraina 927
CN - Cina 749
SE - Svezia 565
VN - Vietnam 548
TR - Turchia 453
HK - Hong Kong 428
BR - Brasile 411
DE - Germania 280
FI - Finlandia 265
IE - Irlanda 241
GB - Regno Unito 239
FR - Francia 205
RU - Federazione Russa 134
CA - Canada 85
IN - India 67
NL - Olanda 60
MX - Messico 59
JP - Giappone 51
BD - Bangladesh 45
PL - Polonia 32
BE - Belgio 28
CZ - Repubblica Ceca 26
ZA - Sudafrica 24
AR - Argentina 23
IQ - Iraq 22
ES - Italia 21
NG - Nigeria 15
PK - Pakistan 13
CL - Cile 11
EU - Europa 11
CH - Svizzera 10
CO - Colombia 10
MD - Moldavia 9
VE - Venezuela 9
AT - Austria 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
MY - Malesia 7
NP - Nepal 7
BG - Bulgaria 6
JO - Giordania 6
KR - Corea 6
LT - Lituania 6
MA - Marocco 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
EC - Ecuador 5
ID - Indonesia 5
IL - Israele 5
KE - Kenya 5
KZ - Kazakistan 5
PE - Perù 5
PY - Paraguay 5
DK - Danimarca 4
DZ - Algeria 4
HU - Ungheria 4
PT - Portogallo 4
RO - Romania 4
TN - Tunisia 4
AL - Albania 3
AZ - Azerbaigian 3
EG - Egitto 3
HN - Honduras 3
NO - Norvegia 3
PA - Panama 3
PS - Palestinian Territory 3
TW - Taiwan 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
OM - Oman 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
SN - Senegal 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 22.754
Città #
Milan 2.035
Fairfield 1.355
Ashburn 947
Woodbridge 851
San Jose 831
Chandler 755
Singapore 734
Jacksonville 711
Houston 678
Seattle 586
Ann Arbor 534
Wilmington 510
Cambridge 467
Hong Kong 421
Dearborn 272
Princeton 257
Nyköping 248
Dublin 240
Beijing 227
Izmir 222
Dallas 217
The Dalles 210
Boardman 180
Como 177
New York 175
Rome 167
Chicago 144
Dong Ket 142
Lauterbourg 120
Council Bluffs 95
San Mateo 94
Los Angeles 92
Ho Chi Minh City 82
San Diego 71
Hanoi 68
Santa Clara 63
London 56
Tokyo 47
Ogden 44
Varese 42
Helsinki 41
São Paulo 40
Mexico City 39
Munich 39
Washington 39
Orem 38
Toronto 38
Norwalk 31
Warsaw 31
Hefei 28
Guangzhou 26
Brussels 25
Brno 24
Chennai 23
Kunming 22
Nanjing 22
Ponte Lambro 22
Denver 21
Montreal 20
Turin 19
Brooklyn 18
Verona 18
Atlanta 17
Frankfurt am Main 17
Mcallen 17
Phoenix 17
Manchester 16
Shanghai 16
Kocaeli 15
Poplar 15
Carbonara Al Ticino 14
Johannesburg 14
Nanchang 14
San Francisco 14
Stockholm 14
Amsterdam 13
Berlin 13
Da Nang 12
Naples 12
Nuremberg 12
Redwood City 12
Shenzhen 12
Abuja 11
Cagliari 11
Jinan 11
Mumbai 11
Ankara 10
Bologna 10
Brescia 10
Paris 10
Rio de Janeiro 10
Brasília 9
Düsseldorf 9
Zhengzhou 9
Baghdad 8
Boston 8
Hangzhou 8
Istanbul 8
Memphis 8
Ottawa 8
Totale 16.246
Nome #
Cannabinoidi ed ansia: meccanismi cellulari/molecolari e ruolo degli endocannabinoidi nella modulazione degli stati ansiosi 433
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex 318
Correlati cellulari e molecolari dell'abuso di Salvia divinorum: ruolo dei recettori cannabici e k oppioidi 313
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats 287
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect 286
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex 282
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice 276
Assay of GTPγS binding in autoradiography 262
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2 261
Adolescent exposure to cannabis as a risk factor for psychiatric disorders 258
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine 251
A molecular basis of analgesic tolerance to cannabinoids 250
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex 247
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour 241
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin 237
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol. 233
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats. 232
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism 229
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats 225
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex 223
Chronic Delta(9)-THC Exposure Differently Affects Histone Modifications in the Adolescent and Adult Rat Brain 219
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence. 218
New vistas on cannabis use disorder 218
Long lasting consequences of cannabis exposure in adolescence. 216
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling 214
Endocannabinoids and Mental Disorders. 212
Cannabinoids and opioids share cAMP pathway in rat splenocytes 209
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine 209
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats. 206
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 204
Role of endocannabinoids in regulating drug dependence 203
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring 203
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats. 199
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids. 198
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models 197
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT? 197
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors. 196
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes 195
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain 192
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood 192
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect. 192
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. 189
Sex-dependent vulnerability to cannabis abuse in adolescence 187
Cannabinoids and Drugs of abuse 186
Cellular mechanisms underlying the interaction between cannabinoid and opioid system 186
The endocannabinoid system and psychiatric disorders. 186
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex 186
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. 185
Endocannabinoids and Drug Dependence 184
The endocannabinoid system and schizophrenia: integration of evidence. 181
Modulation of rat brain cannabinoid receptors after chronic morphine treatment 179
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain 177
Neurobiological mechanisms underlying cannabis-induced memory impairment 176
Endocannabinoids in the immune system and cancer 175
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940 175
Molecular and cellular basis of cannabinoid and opioid interactions 173
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats 173
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system 173
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments 168
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade 168
The psychoactive ingredient of marijuana induces behavioural sensitization 166
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure 165
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects 163
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems 162
Chronic delta 9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. 161
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251. 161
Uso di Cannabis in adolescenza come fattore di rischio per malattie psichiatriche e dipendenza da altre sostanze 158
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages 157
Termination of acute stress response by the endocannabinoid system is regulated through LSD1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL 157
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. 156
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats. 152
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line 151
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization 149
Presence of a reduced opioid response in interleukin-6 knock out mice 149
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models 149
Ruolo emergente dei meccanismi epigenetici e della neuroinfiammazione nei disturbi associate al consume di cannabis 147
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors 146
Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. 146
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models 146
Bombesin receptor antagonist. 2. Analogues based on substance P antagonists 144
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas. 143
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine. 143
Pertussis toxin modifies the effect of central morphine on rat intestinal motility. 142
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study. 142
Behavioral, proteomic and lipidomic analyses in adult male and female rats exposed to cannabinoids during adolescence: an integrative approach to identify markers of vulnerability for psychiatric disorders and drug abuse 141
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition. 141
CB1 cannabinoid and mu opioid receptors density and functionality are altered in rats self-administering either heroin or the CB1 receptor agonist WIN 55,212-2 139
Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition 139
Is cannabinoid transmission involved in rewarding properties of drugs of abuse 138
Modulation of extracellular signal-regulated kinases cascade by cronic Delta(99-tetrahydrocannabinol treatment 138
null 132
Studio sperimentale dell'interazione tra abuso di steroidi anabolizzanti e cannabinoidi nella depressione: dall'analisi comportamentale ai substrati cellulari 131
Pertussis toxin pretreatment affects opiate/nonopiate and stress-induced analgesia differently. 130
Adolescent drug exposure: A review of evidence for the development of persistent changes in brain function 130
Presence of a reduced opioid response in interleukin-6 knock out mice. 129
Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood 129
Chronic Blockade of CB1 Receptors Reverses Startle Gating Deficits and Associated Neurochemical Alterations in Isolation Reared Rats 127
Long-term consequences of adolescent exposure to thc-rich/cbd-poor and cbd-rich/thc-poor combinations: A comparison with pure thc treatment in female rats 127
Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. 126
ERK-dependent modulation of cerebellar synaptic plasticity after chronic Delta 9-tetrahydrocannabinol exposure 124
Totale 18.816
Categoria #
all - tutte 87.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021332 0 0 0 0 0 0 0 0 0 0 0 332
2021/20221.413 144 162 114 183 52 61 61 73 59 209 121 174
2022/20231.951 188 132 123 257 97 417 2 272 249 72 107 35
2023/20243.372 505 534 514 580 623 302 17 69 70 53 36 69
2024/20252.221 43 47 356 91 70 160 112 156 286 195 175 530
2025/20264.970 374 323 157 654 476 351 1.105 330 527 334 224 115
Totale 22.925